Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia
- PMID: 23201839
- PMCID: PMC3509512
- DOI: 10.3390/nu4111664
Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia
Abstract
The loss of muscle mass and strength with aging (i.e., sarcopenia) has a negative effect on functional independence and overall quality of life. One main contributing factor to sarcopenia is the reduced ability to increase skeletal muscle protein synthesis in response to habitual feeding, possibly due to a reduction in postprandial insulin release and an increase in insulin resistance. Branched-chain amino acids (BCAA), primarily leucine, increases the activation of pathways involved in muscle protein synthesis through insulin-dependent and independent mechanisms, which may help counteract the "anabolic resistance" to feeding in older adults. Leucine exhibits strong insulinotropic characteristics, which may increase amino acid availability for muscle protein synthesis, reduce muscle protein breakdown, and enhance glucose disposal to help maintain blood glucose homeostasis.
Figures

Similar articles
-
Diabetes and branched-chain amino acids: What is the link?J Diabetes. 2018 May;10(5):350-352. doi: 10.1111/1753-0407.12645. Epub 2018 Feb 13. J Diabetes. 2018. PMID: 29369529
-
The role of leucine in the regulation of protein metabolism.J Nutr. 2005 Jun;135(6 Suppl):1553S-6S. doi: 10.1093/jn/135.6.1553S. J Nutr. 2005. PMID: 15930468 Review.
-
Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes.Nutr Rev. 2011 Nov;69(11):675-89. doi: 10.1111/j.1753-4887.2011.00443.x. Nutr Rev. 2011. PMID: 22029833 Review.
-
Regulation of cardiac and skeletal muscle protein synthesis by individual branched-chain amino acids in neonatal pigs.Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E612-21. doi: 10.1152/ajpendo.00402.2005. Epub 2005 Nov 8. Am J Physiol Endocrinol Metab. 2006. PMID: 16278252
-
[Amino Acid Nutrition in the Prevention and Treatment of Sarcopenia].Yakugaku Zasshi. 2018;138(10):1277-1283. doi: 10.1248/yakushi.18-00091-4. Yakugaku Zasshi. 2018. PMID: 30270272 Review. Japanese.
Cited by
-
Additive insulinogenic action of Opuntia ficus-indica cladode and fruit skin extract and leucine after exercise in healthy males.J Int Soc Sports Nutr. 2013 Oct 21;10(1):45. doi: 10.1186/1550-2783-10-45. J Int Soc Sports Nutr. 2013. PMID: 24144232 Free PMC article.
-
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy.Diabetes Metab Syndr Obes. 2023 May 30;16:1541-1554. doi: 10.2147/DMSO.S410834. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37275941 Free PMC article. Review.
-
Preoperative administration of branched-chain amino acids reduces postoperative insulin resistance in rats by reducing liver gluconeogenesis.Nutr Metab (Lond). 2022 Nov 29;19(1):78. doi: 10.1186/s12986-022-00710-3. Nutr Metab (Lond). 2022. PMID: 36447227 Free PMC article.
-
Evaluation of sarcopenia in renal transplant recipients.Nephrourol Mon. 2014 Jul 5;6(4):e20055. doi: 10.5812/numonthly.20055. eCollection 2014 Jul. Nephrourol Mon. 2014. PMID: 25695027 Free PMC article.
-
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges.Nutrients. 2021 Aug 10;13(8):2748. doi: 10.3390/nu13082748. Nutrients. 2021. PMID: 34444908 Free PMC article. Review.
References
-
- Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical